Illumina, Inc. (NASDAQ: ILMN) announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, ...

On this episode of GEN Live, we deliver a full debrief on the news from AGBT—critical to understanding where NGS, spatial, single-cell, and multiomics are headed.

Ahead of AGBT, Ultima Genomics launched its UG200 series touting smaller footprint, faster runtime, higher output, and lower pricing.

TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data ...

Chronic inflammation is both a driver and suppressor of cancer depending on context. Key players-NF-κB, IL-6, STAT3, TAMs, MDSCs, and Tregs-orchestrate a tumor-permissive microenvironment.

With an incredibly simple workflow, TruPath Genome eliminates traditional library prep. In just 10-15 minutes of hands-on ...

Endometrial cancer (EC) incidence is rising globally, yet therapeutic progress has lagged behind other solid tumors, in part due to the complexity and ...

Kivu Bioscience, Inc., a clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs) for difficult-to-treat cancers, today announced the presentation of new ...

New commercial kit brings Nature Communications-validated methylation analysis chemistry to researchers working with low-input and cfDNA samplesCAMBRIDGE, ...

Memories are thought to be stored in sparse groups of neurons called engrams. These are the cells that switch on during learning and can later switch on again during recall. In physiological aging and ...

NSCLC remains the leading cause of cancer-related mortality worldwide, with EGFR mutations being a critical driver in approximately 10-15% of lung adenocarcinomas in Western populations, and up to 40% ...

P4ML, a Future100 company headquartered in the UAE, has been named a Founding Member of the Orphan Therapeutics Accelerator (OTXL), expanding OTXL's international capabilities in genomic patient ...